Poseida Therapeutics Inc (PSTX)
9.465
0.00 (0.00%)
USD |
NASDAQ |
Dec 23, 10:46
Poseida Therapeutics Free Cash Flow: -17.13M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Galectin Therapeutics Inc | -33.68M |
| Revance Therapeutics Inc | -194.91M |
| Sage Therapeutics Inc | -320.15M |
| Alector Inc | -222.26M |
| Phathom Pharmaceuticals Inc | -247.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.594M |
| Cash from Investing (Quarterly) | 27.65M |
| Cash from Financing (Quarterly) | 0.742M |
| Free Cash Flow Per Share (Quarterly) | -0.1042 |
| Free Cash Flow to Equity (Quarterly) | -10.35M |
| Free Cash Flow to Firm (Quarterly) | -7.949M |
| Free Cash Flow Yield | -1.87% |